within Pharmacolibrary.Drugs.ATC.D;

model D07BA04
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0002666666666666667,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.04,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D07BA04</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Hydrocortisone and antiseptics is a topical combination medication typically used for the treatment of inflammatory skin disorders with a risk of or presence of secondary infection. Hydrocortisone is a corticosteroid with anti-inflammatory and immunosuppressive properties, while antiseptics such as chlorhexidine are included to reduce microbial colonization. This combination is primarily indicated in dermatology. Hydrocortisone and antiseptics combination is approved for topical use in several countries.</p><h4>Pharmacokinetics</h4><p>No published population or detailed pharmacokinetic models for the fixed combination of hydrocortisone and antiseptics (ATC D07BA04) are available; pharmacokinetic parameters are estimated based on published data for topical hydrocortisone use in adults with healthy or inflamed skin.</p><h4>References</h4><ol><li><p>Siddique, MI, et al., &amp; Jamil, A (2016). In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis. <i>International journal of pharmaceutics</i> 507(1-2) 72–82. DOI:<a href=&quot;https://doi.org/10.1016/j.ijpharm.2016.05.005&quot;>10.1016/j.ijpharm.2016.05.005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27154252/&quot;>https://pubmed.ncbi.nlm.nih.gov/27154252</a></p></li><li><p>Mills, PC, et al., &amp; Cross, SE (2005). Effects of vehicle and region of application on absorption of hydrocortisone through canine skin. <i>American journal of veterinary research</i> 66(1) 43–47. DOI:<a href=&quot;https://doi.org/10.2460/ajvr.2005.66.43&quot;>10.2460/ajvr.2005.66.43</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15691034/&quot;>https://pubmed.ncbi.nlm.nih.gov/15691034</a></p></li><li><p>Kazemi, RB, et al., &amp; Spångberg, LS (1993). Dimensional changes of endodontic sealers. <i>Oral surgery, oral medicine, and oral pathology</i> 76(6) 766–771. DOI:<a href=&quot;https://doi.org/10.1016/0030-4220(93)90050-e&quot;>10.1016/0030-4220(93)90050-e</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8284084/&quot;>https://pubmed.ncbi.nlm.nih.gov/8284084</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D07BA04;
